Home › Funds › Citigroup Inc › IBRX
Citigroup Inc position in IBRX
IMMUNITYBIO INC · Health Care
Latest position (Q2 2026)650.28K sh
Reported value held$5.69M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 184.48K | $1.80M | New |
| Q4 2021 | 383.50K | $2.33M | Add |
| Q1 2022 | 93.17K | $523.00K | Reduce |
| Q2 2022 | 14.73K | $55.00K | Reduce |
| Q3 2022 | 373.64K | $1.86M | Add |
| Q4 2022 | 212.60K | $1.08M | Reduce |
| Q1 2023 | 7.73K | $14.07K | Reduce |
| Q2 2023 | 43.51K | $120.97K | Add |
| Q3 2023 | 6.03K | $10.19K | Reduce |
| Q4 2023 | 312.02K | $1.57M | Add |
| Q1 2024 | 1.13M | $6.06M | Add |
| Q2 2024 | 108.99K | $688.79K | Reduce |
| Q3 2024 | 109.87K | $408.72K | Add |
| Q4 2024 | 384.58K | $984.51K | Add |
| Q1 2025 | 2.71M | $8.17M | Add |
| Q2 2025 | 2.49M | $6.57M | Reduce |
| Q3 2025 | 2.38M | $5.86M | Reduce |
| Q4 2025 | 110.51K | $218.81K | Reduce |
| Q1 2026 | 268.36K | $2.06M | Add |
| Q2 2026 | 650.28K | $5.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IBRX
- BlackRock Inc 34.08M sh · $298.40M · Q2 2026
- D. E. Shaw & Co 11.55M sh · $101.13M · Q2 2026
- Two Sigma Investments 11.10M sh · $97.16M · Q2 2026
- Geode Capital Management 9.85M sh · $86.23M · Q2 2026
- Vanguard Group 32.78M sh · $64.90M · Q4 2025
- Millennium Management 5.58M sh · $48.85M · Q2 2026
- Northern Trust Corp 3.57M sh · $31.21M · Q2 2026
- Morgan Stanley 3.43M sh · $30.05M · Q2 2026
- Goldman Sachs Group 3.23M sh · $28.32M · Q2 2026
- UBS Group AG 3.20M sh · $27.98M · Q2 2026
- Charles Schwab Investment Management 2.89M sh · $25.29M · Q2 2026
- Bank of America Corp 2.18M sh · $19.13M · Q2 2026